Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $4.0 million.

  • Bioventus' Consolidated Net Income changed N/A to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of -$74.4 million for FY2023, which is 827.61% down from last year.
  • Bioventus' Consolidated Net Income amounted to $4.0 million in Q3 2025.
  • Over the past 5 years, Bioventus' Consolidated Net Income peaked at $24.5 million during Q2 2021, and registered a low of -$74.4 million during Q2 2023.
  • Moreover, its 4-year median value for Consolidated Net Income was -$1.3 million (2021), whereas its average is -$10.1 million.
  • In the last 5 years, Bioventus' Consolidated Net Income surged by 13391.19% in 2021 and then crashed by 9348400.0% in 2022.
  • Bioventus' Consolidated Net Income (Quarter) stood at -$25000.0 in 2021, then plummeted by 93484.0% to -$23.4 million in 2022, then plummeted by 218.13% to -$74.4 million in 2023, then surged by 105.38% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $9.3 million for Q2 2025, and -$3.3 million during Q1 2025.